Introducing AcuDart

Partnering with industry leading laboratories to create the most accurate tick-borne disease testing from the comfort of home.

What are IgM Antibodies?

back to glossary >>

IgM antibodies are immune system proteins that serve as the body's first line of defense against infections.

When a pathogen, such as a tick-borne disease (TBD) agent, enters the body, IgM antibodies are among the earliest responders, appearing in the bloodstream within days to weeks. Their primary function is to neutralize invaders and trigger additional immune responses, helping the body combat infections swiftly.

In the context of tick-borne disease testing, IgM detection is crucial for identifying recent or active infections, making it a key marker for early-stage diagnoses.

How IgM Functions in the Immune System

Unlike IgG antibodies, which provide long-term immunity, IgM antibodies are temporary and typically decline after a few months. Their key roles include:

Rapid response: IgM is the first antibody produced when the immune system encounters a new infection.
Pathogen neutralization: It binds to bacteria, viruses, or parasites, preventing them from spreading.
Complement activation: IgM helps initiate a cascade of immune reactions that destroy pathogens.
Immune signaling: It alerts other immune cells to the presence of an infection.

Since IgM is short-lived, its presence in a blood test suggests a recent or ongoing infection rather than past exposure.

The Role of IgM in Tick-Borne Disease Testing

When diagnosing tick-borne infections, healthcare providers rely on IgM tests to detect early-stage illnesses such as Lyme disease, anaplasmosis, and ehrlichiosis.

Common IgM-Based Tests for Tick-Borne Diseases

Western blot (Lyme disease) – Measures IgM response to Borrelia burgdorferi proteins.
ELISA (enzyme-linked immunosorbent assay) – Screens for IgM antibodies to various TBD pathogens.
Immunofluorescence assays (IFA) – Detects IgM antibodies against specific tick-borne microbes like Babesia or Rickettsia.

AcuDart Health offers high-sensitivity IgM testing, often paired with IgG and PCR-based methods to ensure accurate detection across different infection stages.

IgM vs. IgG: Key Differences

IgM and IgG antibodies play complementary roles in immune defense, but they serve different purposes in TBD testing.

Because IgM antibodies naturally fade, a positive IgM test alone does not confirm a long-term infection. This is why AcuDart Health integrates multi-tiered diagnostic strategies, combining IgM testing with IgG, PCR, and antigen detection methods.

Feature

IgM Antibodies

IgG Antibodies

Timing

Appears early (days to weeks)

Develops later (weeks to months)

Duration

Declines after a few months

Can persist for years

Indicates

Recent or active infection

Past exposure or chronic infection

Role in TBD Testing

Helps identify early-stage infections

Used for late-stage or persistent infections

When Should You Consider an IgM Test?

An IgM test may be recommended if you:

Recently had a tick bite and are developing symptoms.
Are experiencing early signs of infection, such as fever, chills, rash, or muscle aches.
Need confirmation of an acute tick-borne illness before starting treatment.

Because IgM antibodies indicate an early immune response, their detection helps doctors diagnose and treat infections before they become chronic.

Final Thoughts

IgM antibodies are critical for identifying early-stage tick-borne diseases. Their presence suggests a recent or active infection, making them valuable for prompt diagnosis and treatment.

However, because they decline over time, they should be interpreted alongside other tests, such as IgG and PCR, to get a full picture of infection status.

AcuDart Health specializes in comprehensive TBD testing, integrating IgM, IgG, and molecular detection methods for highly accurate results. If you suspect a recent tick-borne infection, early testing can be essential for proper diagnosis and care.

Learn more about tick-borne disease diagnostics.

Shop All Tick-Borne Disease Tests

Front of Package for AcuDart Tick-Borne Disease At-Home Screening Test Panel

Back of Package for AcuDart At-Home Screening Tests

Package Contents of AcuDart At-Home Screening Tests

AcuDart Tick-Borne Disease Screening Test Panel

Sample AcuDart Tick-Borne Disease At-Home Screening Test Panel Results Report

AcuDart Tick-Borne Disease Screening Test Panel

$499.00

$596.00

Tick-borne diseases like Lyme disease, Tick-Borne Relapsing Fever (TBRF), Babesiosis, and Bartonellosis share overlapping symptoms, making diagnosis difficult without comprehensive testing. Because these infections can mimic each other, relying on a single test for one disease may lead to missed or delayed diagnoses. That’s why AcuDart offers the most accurate and reliable tick-borne disease testing available.

Unlike standard tests from commercial labs like LabCorp or Quest, which typically screen for just one or two species per disease, the AcuDart Tick-Borne Disease Test Panel is designed for maximum accuracy and coverage. It detects 19 species across four major tick-borne diseases, making it the most comprehensive tick panel on the market. Whether you're experiencing persistent symptoms or have been exposed to ticks, AcuDart's tick-borne disease panel provides the most thorough and precise testing to help you get the right diagnosis and treatment faster.

Quantity